Contact

All Stories

  1. Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrioR) of Chronically HBV Infected Patients

    Article • Journal of Personalized Medicine, March 2024, MDPI AG

    Professor Daniel D Shouval

  2. Hepatitis A virus infection

    Article • Nature Reviews Disease Primers, September 2023, Springer Science + Business Media

    Professor Daniel D Shouval

  3. The History of Hepatitis A

    Article • Clinical Liver Disease, October 2020, Wolters Kluwer Health

    Professor Daniel D Shouval

  4. Hepatitis A and E – Differences and commonalities

    Article • Journal of Hepatology, March 2020, Elsevier

    Professor Daniel D Shouval

  5. Prevention of Hepatitis A

    Article • January 2019, Springer Science + Business Media

    Professor Daniel D Shouval

  6. Viral envelope-specific antibodies in chronic hepatitis B virus infection

    Article • Current Opinion in Virology, June 2018, Elsevier

    Professor Daniel D Shouval

  7. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention

    Article • Journal of Hepatology, January 2018, Elsevier

    Professor Daniel D Shouval

  8. Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groups

    Article • The Journal of Infectious Diseases, December 2016, Oxford University Press (OUP)

    Professor Daniel D Shouval

  9. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines – A systematic review

    Article • Human Vaccines & Immunotherapeutics, October 2016, Taylor & Francis

    Professor Daniel D Shouval

  10. Acute hepatitis E virus in pregnant women in Israel and in other industrialized countries

    Article • Journal of Clinical Virology, December 2015, Elsevier

    Professor Daniel D Shouval

  11. Hepatitis E virus in Israel: A nationwide retrospective study, from a non-endemic country

    Article • Journal of Clinical Virology, August 2015, Elsevier

    Professor Daniel D Shouval

  12. Hepatotoxicity of herbal and dietary supplements: an update

    Article • Archives of Toxicology, February 2015, Springer Science + Business Media

    Professor Daniel D Shouval

  13. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine

    Article • Medical Microbiology and Immunology, January 2015, Springer Science + Business Media

    Professor Daniel D Shouval

  14. Focusing on the past, present, and future of hepatology

    Article • Journal of Hepatology, December 2014, Elsevier

    Professor Daniel D Shouval

  15. Expanding the donor pool for liver transplant recipients using HBsAg positive grafts

    Article • Journal of Hepatology, October 2014, Elsevier

    Professor Daniel D Shouval

  16. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine

    Article • Vaccine, September 2014, Elsevier

    Professor Daniel D Shouval, Professor MICHAEL C.M. ROGGENDORF

  17. O-01: IL-10 receptor dependent signals regulate the generation and function of anti-inflammatory macrophages in mice and humans

    Article • Journal of Crohn s and Colitis, September 2014, Oxford University Press (OUP)

    Professor Daniel D Shouval

  18. The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation

    Article • Journal of Hepatology, August 2014, Elsevier

    Professor Daniel D Shouval

  19. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation

    Article • Journal of Hepatology, June 2014, Elsevier

    Professor Daniel D Shouval

  20. Commonly Found Variations/Mutations in the HBsAg of Hepatitis B Virus in the Context of Effective Immunization Programs: Questionable Clinical and Public Health Significance

    Article • Journal of Virology, May 2014, ASM Journals

    Professor Daniel D Shouval

  21. Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database

    Article • Liver International, April 2014, Wiley

    Professor Daniel D Shouval

  22. The impact of chronic hepatitis C infection on the circadian clock and sleep

    Article • Journal of Hepatology, April 2014, Elsevier

    Professor Daniel D Shouval

  23. Focus

    Article • Journal of Hepatology, February 2014, Elsevier

    Professor Daniel D Shouval

  24. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study

    Article • Journal of Hepatology, February 2014, Elsevier

    Professor Daniel D Shouval

  25. Hepatitis A Virus

    Article • January 2014, Springer Science + Business Media

    Professor Daniel D Shouval

  26. Focus

    Article • Journal of Hepatology, December 2013, Elsevier

    Professor Daniel D Shouval

  27. Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype

    Article • Journal of Hepatology, December 2013, Elsevier

    Professor Daniel D Shouval

  28. Focus

    Article • Journal of Hepatology, October 2013, Elsevier

    Professor Daniel D Shouval

  29. Focus

    Article • Journal of Hepatology, August 2013, Elsevier

    Professor Daniel D Shouval

  30. The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference

    Article • Journal of Viral Hepatitis, July 2013, Wiley

    Professor Daniel D Shouval

  31. Immunosuppression and HBV Reactivation

    Article • Seminars in Liver Disease, June 2013, Thieme Publishing Group

    Professor Daniel D Shouval

  32. Focus

    Article • Journal of Hepatology, June 2013, Elsevier

    Professor Daniel D Shouval

  33. Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

    Article • Journal of Hepatology, June 2013, Elsevier

    Professor Daniel D Shouval

  34. Focus

    Article • Journal of Hepatology, April 2013, Elsevier

    Professor Daniel D Shouval

  35. Focus

    Article • Journal of Hepatology, February 2013, Elsevier

    Professor Daniel D Shouval

  36. Hepatitis B vaccines

    Article • January 2013, Elsevier

    Professor Daniel D Shouval

  37. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Daniel D Shouval

  38. Focus

    Article • Journal of Hepatology, December 2012, Elsevier

    Professor Daniel D Shouval

  39. Tracing hepatitis B virus to the 16th century in a Korean mummy

    Article • Hepatology, October 2012, Wiley

    Professor Daniel D Shouval

  40. Focus

    Article • Journal of Hepatology, October 2012, Elsevier

    Professor Daniel D Shouval

  41. Focus

    Article • Journal of Hepatology, August 2012, Elsevier

    Professor Daniel D Shouval

  42. Increased Prevalence of HBV Envelope Mutants in Taiwan: An Emerging Public Health Risk or a False Alarm?

    Article • Gastroenterology, August 2012, Elsevier

    Professor Daniel D Shouval

  43. Breastmilk Hepatitis A Virus RNA in Nursing Mothers with Acute Hepatitis A Virus Infection

    Article • Breastfeeding Medicine, August 2012, Mary Ann Liebert Inc

    Professor Daniel D Shouval

  44. Focus

    Article • Journal of Hepatology, June 2012, Elsevier

    Professor Daniel D Shouval

  45. New doubts about preventing HAV superinfection in chronic HCV

    Article • Nature Reviews Gastroenterology & Hepatology, May 2012, Springer Science + Business Media

    Professor Daniel D Shouval

  46. Focus

    Article • Journal of Hepatology, April 2012, Elsevier

    Professor Daniel D Shouval

  47. 1030 TRANS-ARTERIAL CHEMO-EMBOLIZATION (TACE) IS SAFE AND EFFICIENT FOR ELDERLY PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC): RESULTS FROM AN INTERNATIONAL META-DATABASE

    Article • Journal of Hepatology, April 2012, Elsevier

    Professor Daniel D Shouval

  48. Hepatocellular carcinoma

    Article • The Lancet, March 2012, Elsevier

    Professor Daniel D Shouval

  49. Focus

    Article • Journal of Hepatology, February 2012, Elsevier

    Professor Daniel D Shouval

  50. Hepatitis A

    Article • January 2012, Elsevier

    Professor Daniel D Shouval

  51. Focus

    Article • Journal of Hepatology, December 2011, Elsevier

    Professor Daniel D Shouval

  52. Focus

    Article • Journal of Hepatology, October 2011, Elsevier

    Professor Daniel D Shouval

  53. Focus

    Article • Journal of Hepatology, August 2011, Elsevier

    Professor Daniel D Shouval

  54. Telaprevir for Retreatment of HCV Infection

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2011, New England Journal of Medicine (NEJM/MMS)

    Professor Daniel D Shouval, Professor Eric J Lawitz, Prof. Dr. Bart van Hoek

  55. Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2011, New England Journal of Medicine (NEJM/MMS)

    Professor Daniel D Shouval

  56. Focus

    Article • Journal of Hepatology, June 2011, Elsevier

    Professor Daniel D Shouval

  57. Focus

    Article • Journal of Hepatology, April 2011, Elsevier

    Professor Daniel D Shouval

  58. Focus

    Article • Journal of Hepatology, February 2011, Elsevier

    Professor Daniel D Shouval

  59. Focus

    Article • Journal of Hepatology, January 2011, Elsevier

    Professor Daniel D Shouval

  60. Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting

    Article • World Journal of Hepatology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Daniel D Shouval

  61. Focus

    Article • Journal of Hepatology, December 2010, Elsevier

    Professor Daniel D Shouval

  62. Focus

    Article • Journal of Hepatology, November 2010, Elsevier

    Professor Daniel D Shouval

  63. Focus

    Article • Journal of Hepatology, October 2010, Elsevier

    Professor Daniel D Shouval

  64. Focus

    Article • Journal of Hepatology, September 2010, Elsevier

    Professor Daniel D Shouval

  65. Focus

    Article • Journal of Hepatology, August 2010, Elsevier

    Professor Daniel D Shouval

  66. The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients

    Article • Digestive and Liver Disease, August 2010, Elsevier

    Professor Daniel D Shouval

  67. Focus

    Article • Journal of Hepatology, July 2010, Elsevier

    Professor Daniel D Shouval

  68. Focus

    Article • Journal of Hepatology, June 2010, Elsevier

    Professor Daniel D Shouval

  69. Focus

    Article • Journal of Hepatology, May 2010, Elsevier

    Professor Daniel D Shouval

  70. Focus

    Article • Journal of Hepatology, April 2010, Elsevier

    Professor Daniel D Shouval

  71. 591 TRANS ARTERIAL CHEMO-EMBOLIZATION (TACE) IS A SAFE AND EFFECTIVE TREATMENT FOR VERY ELDERLY PATIENTS WITH HEPATOCELLULR CARCINOMA (HCC)

    Article • Journal of Hepatology, April 2010, Elsevier

    Professor Daniel D Shouval

  72. Focus

    Article • Journal of Hepatology, March 2010, Elsevier

    Professor Daniel D Shouval

  73. Focus

    Article • Journal of Hepatology, February 2010, Elsevier

    Professor Daniel D Shouval

  74. Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management

    Article • Liver International, February 2010, Wiley

    Professor Daniel D Shouval

  75. Strategies for Global Prevention of Hepatitis B Virus Infection

    Article • October 2009, Springer Science + Business Media

    Professor Daniel D Shouval

  76. Prof. Daniel Shouval

    Article • Journal of Hepatology, October 2009, Elsevier

    Professor Daniel D Shouval

  77. 482 OUTCOME COMPARISON OF PERCUTANEOUS AND SURGICAL INTERVENTIONS IN PATIENTS WITH BUDD-CHIARI SYNDROME- A LONGITUDINAL SINGLE CENTER EXPERIENCE

    Article • Journal of Hepatology, April 2009, Elsevier

    Professor Daniel D Shouval

  78. Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

    Article • Journal of Hepatology, February 2009, Elsevier

    Professor Daniel D Shouval

  79. EASL Clinical Practice Guidelines: Management of chronic hepatitis B

    Article • Journal of Hepatology, February 2009, Elsevier

    Professor Daniel D Shouval

  80. Hepatitis B Vaccines

    Article • January 2009, Springer Science + Business Media

    Professor Daniel D Shouval

  81. 9.16 Chronic hepatitis and other liver disease

    Article • January 2009, Oxford University Press (OUP)

    Professor Daniel D Shouval

  82. Mononeuritis multiplex: a rare complication of acute hepatitis A

    Article • Liver International, December 2008, Wiley

    Professor Daniel D Shouval

  83. The global impact of vaccination against hepatitis B: A historical overview

    Article • Vaccine, November 2008, Elsevier

    Professor Daniel D Shouval

  84. Statements from the Taormina expert meeting on occult hepatitis B virus infection

    Article • Journal of Hepatology, October 2008, Elsevier

    Professor Daniel D Shouval

  85. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology

    Article • Journal of Viral Hepatitis, August 2008, Wiley

    Professor Daniel D Shouval

  86. Herbalife revisited: Reply

    Article • Journal of Hepatology, August 2008, Elsevier

    Professor Daniel D Shouval

  87. More reports of potential hepatotoxicity of Herbalife products: Reply

    Article • Journal of Hepatology, August 2008, Elsevier

    Professor Daniel D Shouval

  88. Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C

    Article • Hepatology, August 2008, Wolters Kluwer Health

    Professor Daniel D Shouval

  89. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries

    Article • Occupational and Environmental Medicine, July 2008, BMJ

    Professor Daniel D Shouval

  90. β-Glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: A novel adjuvant for HBV vaccination

    Article • Vaccine, May 2008, Elsevier

    Professor Daniel D Shouval

  91. What is the clinical significance of the high prevalence of occult hepatitis B in US liver transplant patients with chronic hepatitis C?

    Article • Liver Transplantation, January 2008, Wiley

    Professor Daniel D Shouval

  92. Hepatitis A and B vaccination and public health

    Article • Journal of Viral Hepatitis, October 2007, Wiley

    Professor Daniel D Shouval

  93. Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity

    Article • Journal of Hepatology, October 2007, Elsevier

    Professor Daniel D Shouval

  94. Prevención de la reactivación de hepatitis B en pacientes inmunodeprimidos y con neoplasia

    Article • Medwave, July 2007, Academy of Sciences and Arts of the Republic of Srpska

    Professor Daniel D Shouval

  95. Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules

    Article • Vaccine, May 2007, Elsevier

    Professor Daniel D Shouval

  96. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies

    Article • British Journal of Haematology, March 2007, Wiley

    Professor Daniel D Shouval

  97. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine

    Article • Vaccine, April 2006, Elsevier

    Professor Daniel D Shouval

  98. Acute Hepatitis A Infection in Pregnancy Is Associated With High Rates of Gestational Complications and Preterm Labor

    Article • Gastroenterology, April 2006, Elsevier

    Professor Daniel D Shouval

  99. 45 Continued virologic and biochemical improvement through 96 weeks of entecavir treatment in HBeAg(−) chronic hepatitis B patients (study ETV-027)

    Article • Journal of Hepatology, April 2006, Elsevier

    Professor Daniel D Shouval

  100. 733 Interim (week 12) phase 2b virological efficacy and safety results of albumin interferon Alpha-2b combined with ribavirin in genotype 1 chronic hepatitis C infection

    Article • Journal of Hepatology, April 2006, Elsevier

    Professor Daniel D Shouval

  101. Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2006, New England Journal of Medicine (NEJM/MMS)

    Professor Daniel D Shouval, Professor Vladimir V Rafalskiy

  102. Graft-Versus-Host Disease and the Liver

    Article • January 2006, Elsevier

    Professor Daniel D Shouval

  103. Adoptive transfer of immunity to HBV in liver transplant patients:A step forward toward the proof of concept for therapeutic vaccination or a transient immunologic phenomenon?

    Article • Liver Transplantation, January 2006, Wolters Kluwer Health

    Professor Daniel D Shouval

  104. P.082 Entecavir (ETV) treatment through 96 weeks results in virologic and biochemical improvement in HBeAg(-) chronic hepatitis B patients (study ETV-027)

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Daniel D Shouval

  105. O.127 Phase 2b interim (week 12) results of albumin interferon alpha-2b combined with ribavirin in IFN-naïve, genotype 1 chronic hepatitis C infection

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Professor Daniel D Shouval

  106. The questionable role of immunization against hepatitis B in HBV infected liver transplant patients

    Article • Journal of Hepatology, August 2005, Elsevier

    Professor Daniel D Shouval

  107. Incidence of Hepatitis A in Israel Following Universal Immunization of Toddlers

    Article • JAMA, July 2005, American Medical Association (AMA)

    Professor Daniel D Shouval

  108. Vaccination against hepatitis B and C: the state of the art

    Article • Hot Topics in Viral Hepatitis, January 2005, FB Communication

    Professor Daniel D Shouval

  109. Air transportation of patients with end-stage liver disease to distant liver transplantation centers

    Article • Liver Transplantation, January 2005, Wiley

    Professor Daniel D Shouval

  110. Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs

    Article • Journal of Hepatology, December 2004, Elsevier

    Professor Daniel D Shouval

  111. Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation

    Article • Clinical Transplantation, August 2004, Wiley

    Professor Daniel D Shouval

  112. REDUCED INCIDENCE OF HYPERURICEMIA, GOUT, AND RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION IN COMPARISON TO HEART TRANSPLANTATION: A LONG-TERM FOLLOW-UP STUDY

    Article • Transplantation, May 2004, Wolters Kluwer Health

    Professor Daniel D Shouval

  113. Prevention of hepatitis C virus infection*

    Article • Journal of Viral Hepatitis, May 2004, Wiley

    Professor Geert Leroux-Roels, Professor Daniel D Shouval

  114. Late cytomegalovirus disease following liver transplantation

    Article • Transplant International, December 2003, Frontiers

    Professor Daniel D Shouval

  115. Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats

    Article • Journal of Hepatology, October 2003, Elsevier

    Professor Daniel D Shouval, Dr Alicia G Fuchs

  116. Hepatitis A booster vaccination: is there a need?

    Article • The Lancet, September 2003, Elsevier

    Professor Geert Leroux-Roels, Professor Daniel D Shouval

  117. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients

    Article • Journal of Clinical Virology, August 2003, Elsevier

    Professor Daniel D Shouval

  118. Universal hepatitis A vaccination of young children is leading to disappearance of hepatitis A in adolescents and adults

    Article • Journal of Hepatology, April 2003, Elsevier

    Professor Daniel D Shouval

  119. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon

    Article • The Pediatric Infectious Disease Journal, March 2003, Wolters Kluwer Health

    Professor Daniel D Shouval

  120. Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature

    Article • Transplantation Proceedings, March 2003, Elsevier

    Professor Daniel D Shouval

  121. Article • The Pediatric Infectious Disease Journal, March 2003, Wolters Kluwer Health

    Professor Daniel D Shouval

  122. Hepatitis B vaccines

    Article • Journal of Hepatology, January 2003, Elsevier

    Professor Daniel D Shouval

  123. Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation

    Article • The American Journal of Gastroenterology, January 2003, Wolters Kluwer Health

    Professor Daniel D Shouval

  124. Adoptive immune transfer as a therapeutic approach for persistent hepatitis B virus infection

    Article • January 2003, Elsevier

    Professor Daniel D Shouval

  125. Late cytomegalovirus disease following liver transplantation

    Article • Transplant International, December 2002, Frontiers

    Professor Daniel D Shouval

  126. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

    Article • Blood, July 2002, American Society of Hematology

    Professor Daniel D Shouval

  127. Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis

    Article • Journal of Clinical Gastroenterology, July 2002, Wolters Kluwer Health

    Professor Daniel D Shouval

  128. HCC: What's the score

    Article • Gut, June 2002, BMJ

    Professor Daniel D Shouval

  129. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance

    Article • Transplantation, March 2002, Wolters Kluwer Health

    Professor Daniel D Shouval

  130. Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties

    Article • Hepatology, March 2002, Wolters Kluwer Health

    Professor Daniel D Shouval

  131. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors

    Article • Gut, January 2002, BMJ

    Professor Daniel D Shouval

  132. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system

    Article • Immunology, December 2001, Wiley

    Professor Daniel D Shouval

  133. Hepatitis C Virus Infection in Employees of a Large University Hospital in Israel

    Article • Infection Control, December 2001, Cambridge University Press

    Professor Daniel D Shouval

  134. Announcements

    Article • Neurosurgery, August 2001, Wolters Kluwer Health

    Professor Daniel D Shouval

  135. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine

    Article • Gut, June 2001, BMJ

    Professor Daniel D Shouval

  136. Hyper-IL-6 Gene Therapy Reverses Fulminant Hepatic Failure

    Article • Molecular Therapy, May 2001, Elsevier

    Professor Daniel D Shouval

  137. Prophylactic lamivudine therapy may prevent immunosuppressive induced HBV reactivation in chronic carriers

    Article • Journal of Hepatology, April 2001, Elsevier

    Professor Daniel D Shouval

  138. Hepatocellular carcinoma

    Article • Annals of Oncology, February 2001, Elsevier

    Professor Daniel D Shouval

  139. Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity

    Article • Journal of Hepatology, January 2001, Elsevier

    Professor Daniel D Shouval

  140. Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine

    Article • Journal of Hepatology, January 2001, Elsevier

    Professor Daniel D Shouval

  141. Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients

    Article • Mediators of Inflammation, January 2001, Wiley

    Professor Daniel D Shouval

  142. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation

    Article • British Journal of Pharmacology, January 2001, Springer Science + Business Media

    Professor Daniel D Shouval

  143. TT Virus Infection in Israeli Patients with Fulminant Hepatic Failure

    Article • Vox Sanguinis, December 2000, Wiley

    Professor Daniel D Shouval

  144. Is universal vaccination against hepatitis B sufficient for control of HBV infection? Lessons from the immunization campaign in Italy

    Article • Journal of Hepatology, December 2000, Elsevier

    Professor Daniel D Shouval

  145. Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: A concise review

    Article • Hepatology, December 2000, Wolters Kluwer Health

    Professor Daniel D Shouval

  146. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients

    Article • British Journal of Pharmacology, September 2000, Springer Science + Business Media

    Professor Daniel D Shouval

  147. Preclinical Evaluation of Two Human Anti–Hepatitis B Virus(HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees

    Article • Hepatology, September 2000, Wiley

    Professor Daniel D Shouval

  148. Reply

    Article • The Journal of Infectious Diseases, September 2000, Oxford University Press (OUP)

    Professor Daniel D Shouval

  149. Transient Transmission of Hepatitis C Virus from Mothers to Newborns

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 2000, Springer Science + Business Media

    Professor Daniel D Shouval

  150. Human Interleukin-6 Facilitates Hepatitis B Virus Infection in Vitro and in Vivo

    Article • Virology, May 2000, Elsevier

    Professor Daniel D Shouval

  151. Human liver micro-organs transcribe albumin and clotting factors in an in vivo perfusion model

    Article • Gastroenterology, April 2000, Elsevier

    Professor Daniel D Shouval

  152. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome

    Article • Journal of Hepatology, April 2000, Elsevier

    Professor Daniel D Shouval

  153. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the Trimera mouse

    Article • Hepatology, February 2000, Wiley

    Professor Daniel D Shouval

  154. The trimera mouse system: A model for HCV infection and evaluation of antiviral drugs

    Article • Journal of Hepatology, January 2000, Elsevier

    Professor Daniel D Shouval

  155. HBIG in patients liver transplanted with HBc positive donors

    Article • Journal of Hepatology, January 2000, Elsevier

    Professor Daniel D Shouval

  156. Residual viral B particles at 10 years post trans-plantation in patients receiving long term anti-HBs immunoglobulins (HBIG)

    Article • Journal of Hepatology, January 2000, Elsevier

    Professor Daniel D Shouval

  157. TT Virus Infection in Israeli Patients with Fulminant Hepatic Failure

    Article • Vox Sanguinis, January 2000, Wiley

    Professor Daniel D Shouval

  158. Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

    Article • The Journal of Infectious Diseases, December 1999, Oxford University Press (OUP)

    Professor Daniel D Shouval

  159. “Silent” presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection

    Article • Hepatology, November 1999, Wiley

    Professor Daniel D Shouval

  160. Hepatitis A vaccine for secondary hepatitis A infection

    Article • The Lancet, July 1999, Elsevier

    Professor Daniel D Shouval

  161. Will transplantation of an hepatitis C–infected graft improve the outcome of liver transplantation in HCV patients?

    Article • Gastroenterology, July 1999, Elsevier

    Professor Daniel D Shouval

  162. The role of ERCP in biliary complications after liver transplantation

    Article • Transplantation Proceedings, June 1999, Elsevier

    Professor Daniel D Shouval

  163. Comparison of immunogenicity of two hepatitis A vaccines — VAQTA® and HAVRIX® — in young adults

    Article • Vaccine, May 1999, Elsevier

    Professor Daniel D Shouval

  164. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation

    Article • Hepatology, April 1999, Wiley

    Professor Daniel D Shouval

  165. Increased risk of exposure to hepatitis b infection among butchers sharing knives

    Article • The American Journal of Medicine, April 1999, Elsevier

    Professor Daniel D Shouval

  166. Antigen‐specific B and T cells in human/mouse radiation chimera following immunization in vivo

    Article • Immunology, April 1999, Wiley

    Professor Daniel D Shouval

  167. The hepatitis B virus-trimera mouse: A model for human HBV infection and evaluation of anti-HBV therapeutic agents

    Article • Hepatology, February 1999, Wiley

    Professor Daniel D Shouval

  168. Chapter 9. A Professor of Phonetics (1919-21)

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  169. Contents

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  170. List of illustrations

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  171. Chapter 8. The Outline

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  172. Preface

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  173. Appendix. Historical Background

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  174. References

    Article • December 1998, De Gruyter

    Professor Daniel D Shouval

  175. Vaccines for prevention of viral hepatitis

    Article • Haemophilia, July 1998, Wiley

    Professor Daniel D Shouval

  176. Psychological distress in patients with chronic, nonalcoholic, uncomplicated liver disease

    Article • Journal of Psychosomatic Research, May 1998, Elsevier

    Professor Daniel D Shouval

  177. Liver Transplantation Across the ABO Barrier: The Role of Plasmapheresis

    Article • Transplantation Proceedings, May 1998, Elsevier

    Professor Daniel D Shouval

  178. Octreotide in hepatocellular carcinoma

    Article • Gut, March 1998, BMJ

    Professor Daniel D Shouval

  179. The HBV trimera mouse: a model for human HBV infection and evaluation of anti-viral agents

    Article • Journal of Hepatology, January 1998, Elsevier

    Professor Daniel D Shouval

  180. Natural course of de novo hepatitis B virus infection in liver transplant recipients

    Article • Transplantation Proceedings, September 1997, Elsevier

    Professor Daniel D Shouval

  181. Hepatitis-C-associated cryoglobulinemia after liver transplantation

    Article • Transplantation Proceedings, September 1997, Elsevier

    Professor Daniel D Shouval

  182. Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?

    Article • Transplantation Proceedings, September 1997, Elsevier

    Professor Daniel D Shouval

  183. Natural course of HCV viremia following liver transplantation and clinical course of reinfection

    Article • Transplantation Proceedings, September 1997, Elsevier

    Professor Daniel D Shouval

  184. Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen

    Article • Journal of Hepatology, July 1997, Elsevier

    Professor Daniel D Shouval

  185. Comparison of methods for extraction of nucleic acid from hemolytic serum for PCR amplification of hepatitis B virus DNA sequences

    Article • Journal of Clinical Microbiology, July 1997, ASM Journals

    Professor Daniel D Shouval

  186. Article • Digestive Diseases and Sciences, January 1997, Springer Science + Business Media

    Professor Daniel D Shouval

  187. Hepatitis A Prophylaxis

    Article • Clinical Immunotherapeutics, October 1996, Springer Science + Business Media

    Professor Daniel D Shouval

  188. Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation

    Article • Liver Transplantation and Surgery, July 1996, Wiley

    Professor Daniel D Shouval

  189. Need for liver transplantation

    Article • The Lancet, July 1996, Elsevier

    Professor Daniel D Shouval

  190. Esophageal Malignancy after Liver Transplantation in a Patient with Barrett's Esophagus

    Article • Scandinavian Journal of Gastroenterology, January 1996, Taylor & Francis

    Professor Daniel D Shouval

  191. Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report

    Article • Journal of Viral Hepatitis, January 1996, Wiley

    Professor Daniel D Shouval

  192. Adoptive transfer of immunity to hepatitis B: development of the concept and evolution of the research project for targeted immunotherapy against hepatic cells which express a viral antigen

    Article • Advanced Drug Delivery Reviews, December 1995, Elsevier

    Professor Daniel D Shouval

  193. The need for liver transplantation: a nationwide estimate based on consensus review

    Article • The Lancet, September 1995, Elsevier

    Professor Daniel D Shouval

  194. Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus

    Article • Journal of Hepatology, July 1995, Elsevier

    Professor Daniel D Shouval

  195. Hepatitis C Virus Viremia in SCID -> BNX Mouse Chimera

    Article • The Journal of Infectious Diseases, July 1995, Oxford University Press (OUP)

    Professor Daniel D Shouval

  196. Hepatitis A virus and polymerase chain reaction amplification

    Article • Blood Coagulation & Fibrinolysis, July 1995, Wolters Kluwer Health

    Professor Daniel D Shouval

  197. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma

    Article • Cancer, May 1995, Wiley

    Professor Daniel D Shouval

  198. Correction of ?-glucuronidase deficiency in mice by intrasplenic transplantation of isolated hepatocytes

    Article • International Hepatology Communications, February 1995, Elsevier

    Professor Daniel D Shouval

  199. Aorto-atrial fistula following internal jugular vein catheterization

    Article • European Heart Journal, February 1995, Oxford University Press (OUP)

    Professor Daniel D Shouval

  200. Immunization against Hepatitis B through Adoptive Transfer of Immunity

    Article • Intervirology, January 1995, Karger Publishers

    Professor Daniel D Shouval

  201. Exposure to hepatitis B and C and to HTLV‐1 and 2 among Israeli drug abusers in Jerusalem

    Article • Addiction, July 1994, Wiley

    Professor Daniel D Shouval

  202. Round Table Discussion

    Article • Vox Sanguinis, June 1994, Wiley

    Professor Daniel D Shouval

  203. A Double Virus‐Inactivated Factor VIII Preparation: Validation and Biochemical Characteristics

    Article • Vox Sanguinis, June 1994, Wiley

    Professor Daniel D Shouval

  204. Hepatitis A Virus Infection among the Hemophilia Population at the Bonn Hemophilia Center

    Article • Vox Sanguinis, June 1994, Wiley

    Professor Daniel D Shouval

  205. Inactivation of Hepatitis A Virus by Pasteurization and Elimination of Picornaviruses during Manufacture of Factor VIII Concentrate

    Article • Vox Sanguinis, June 1994, Wiley

    Professor Daniel D Shouval

  206. Sequence Variability of Hepatitis A Virus and Factor VIII Associated Hepatitis A Infections in Hemophilia Patients in Europe: An Update

    Article • Vox Sanguinis, June 1994, Wiley

    Professor Daniel D Shouval

  207. A New Vaccine for the Prevention of Hepatitis A: Summary of a Satellite Symposium

    Article • January 1994, Springer Science + Business Media

    Professor Daniel D Shouval

  208. Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors

    Article • January 1994, Springer Science + Business Media

    Professor Daniel D Shouval

  209. Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report

    Article • January 1994, Springer Science + Business Media

    Professor Daniel D Shouval

  210. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes

    Article • Journal of Hepatology, January 1994, Elsevier

    Professor Daniel D Shouval

  211. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

    Article • Vaccine, January 1994, Elsevier

    Professor Daniel D Shouval

  212. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation

    Article • Hepatology, August 1993, Elsevier

    Professor Daniel D Shouval

  213. Sclerosing cholangitis associated with Crohn's disease and autoimmune haemolytic anaemia

    Article • Postgraduate Medical Journal, August 1993, Oxford University Press (OUP)

    Professor Daniel D Shouval

  214. IgA deficiency associated with chronic hepatitis C virus infection. A cause or an effect?

    Article • Archives of Internal Medicine, July 1993, American Medical Association (AMA)

    Professor Daniel D Shouval

  215. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors

    Article • Hepatology, June 1993, Wiley

    Professor Daniel D Shouval

  216. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor

    Article • Gastroenterology, June 1993, Elsevier

    Professor Daniel D Shouval

  217. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors

    Article • Hepatology, June 1993, Elsevier

    Professor Daniel D Shouval

  218. Foreword

    Article • Journal of Hepatology, January 1993, Elsevier

    Professor Daniel D Shouval

  219. Excessive Hepatitis-B Surface Antigen Production After Corticosteroids and the Development of Immunoblastic Lymphoma

    Article • Leukemia & Lymphoma, January 1993, Taylor & Francis

    Professor Daniel D Shouval

  220. Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin

    Article • Journal of Hepatology, January 1993, Elsevier

    Professor Daniel D Shouval

  221. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial

    Article • Journal of Hepatology, January 1993, Elsevier

    Professor Daniel D Shouval

  222. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

    Article • Journal of Hepatology, January 1993, Elsevier

    Professor Daniel D Shouval

  223. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis

    Article • Vaccine, January 1993, Elsevier

    Professor Daniel D Shouval

  224. A finger-stick assay for determination of immunity to hepatitis A: a preliminary report

    Article • Journal of Hepatology, January 1993, Elsevier

    Professor Daniel D Shouval

  225. Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.

    Article • Journal of Epidemiology & Community Health, December 1992, BMJ

    Professor Daniel D Shouval

  226. SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS

    Article • International Journal of Immunogenetics, October 1992, Wiley

    Professor Daniel D Shouval

  227. Liver Failure and the Sea-Blue Histocyte/Adult Niemann—Pick Disease

    Article • Journal of Clinical Gastroenterology, September 1992, Wolters Kluwer Health

    Professor Daniel D Shouval

  228. A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 1992, New England Journal of Medicine (NEJM/MMS)

    Professor Daniel D Shouval

  229. Immunotargeting of daunomycin to localized and metastatic human colon adenocarcinoma in athymic mice

    Article • Medical Oncology, May 1992, Springer Science + Business Media

    Professor Daniel D Shouval

  230. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines

    Article • Medical Oncology, March 1992, Springer Science + Business Media

    Professor Daniel D Shouval

  231. Relapsing Hepatitis A Review of 14 Cases and Literature Survey

    Article • Medicine, January 1992, Wolters Kluwer Health

    Professor Daniel D Shouval

  232. p53 mutation in hepatocellular carcinoma after aflatoxin exposure

    Article • The Lancet, November 1991, Elsevier

    Professor Daniel D Shouval

  233. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk

    Article • Journal of Medical Virology, August 1991, Wiley

    Professor Daniel D Shouval

  234. Localized primary sclerosing cholangitis mimicking a cholecystectomy stricture relieved by an endoprosthesis

    Article • Postgraduate Medical Journal, May 1991, Oxford University Press (OUP)

    Professor Daniel D Shouval

  235. Reply

    Article • American Journal of Obstetrics and Gynecology, January 1991, Elsevier

    Professor Daniel D Shouval

  236. A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma

    Article • Bioconjugate Chemistry, July 1990, American Chemical Society (ACS)

    Professor Daniel D Shouval

  237. Postpartum Budd-Chiari syndrome with prolongedhypercoagulability state

    Article • American Journal of Obstetrics and Gynecology, May 1990, Elsevier

    Professor Daniel D Shouval

  238. The effect of anti-α-fetoprotein-adriamycin conjugate on a human hepatoma

    Article • Hepatology, April 1990, Wiley

    Professor Daniel D Shouval

  239. Hepatitis during measles in young adults: Possible role of antipyretic drugs

    Article • Hepatology, August 1989, Wiley

    Professor Daniel D Shouval

  240. Detection of hepatitis a virus rna in serum from patients with acute hepatitis

    Article • Journal of Medical Virology, August 1989, Wiley

    Professor Daniel D Shouval

  241. A Common-Source Outbreak of Fulminant Hepatitis B in a Hospital

    Article • Annals of Internal Medicine, May 1989, American College of Physicians

    Professor Daniel D Shouval

  242. Radioimmunolocation of Hepatic and Pulmonary Metastasis of Human Colon Adenocarcinoma

    Article • Gastroenterology, May 1989, Elsevier

    Professor Daniel D Shouval

  243. In Vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma

    Article • Hepatology, April 1989, Wiley

    Professor Daniel D Shouval

  244. Improvement of Immune-Complex Nephritis Associated with Hepatitis B Surface Antigen Excess

    Article • American Journal of Nephrology, January 1989, Karger Publishers

    Professor Daniel D Shouval

  245. Measles

    Article • Southern Medical Journal, November 1988, Southern Medical Association

    Professor Daniel D Shouval

  246. Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.

    Article • Proceedings of the National Academy of Sciences, November 1988, Proceedings of the National Academy of Sciences

    Professor Daniel D Shouval

  247. An acupuncture-associated outbreak of hepatitis B in Jerusalem

    Article • European Journal of Epidemiology, September 1988, Springer Science + Business Media

    Professor Daniel D Shouval

  248. Sublines of the Burkitt line Daudi, selected on the basis of reactivity with soybean agglutinin, differ in tumorigenicity in athymic mice

    Article • Immunology Letters, July 1988, Elsevier

    Professor Daniel D Shouval

  249. Production of Erythropoietin by an Established Human Renal Carcinoma Cell Line: In Vitro and In Vivo Studies

    Article • January 1988, Springer Science + Business Media

    Professor Daniel D Shouval

  250. Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice

    Article • Virchows Archiv A Pathological Anatomy and Histopathology, January 1988, Springer Science + Business Media

    Professor Daniel D Shouval

  251. Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-HEP-1

    Article • Cancer Letters, March 1987, Elsevier

    Professor Daniel D Shouval

  252. Recombinant alpha interferon suppresses HBV enhancer activity

    Article • Journal of Hepatology, January 1987, Elsevier

    Professor Daniel D Shouval

  253. Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue

    Article • British Journal of Cancer, November 1986, Springer Science + Business Media

    Professor Daniel D Shouval

  254. Continuous production of erythropoietin by an established human renal carcinoma cell line: development of the cell line.

    Article • Proceedings of the National Academy of Sciences, January 1986, Proceedings of the National Academy of Sciences

    Professor Daniel D Shouval

  255. Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside

    Article • Journal of Hepatology, January 1986, Elsevier

    Professor Daniel D Shouval

  256. Papular Acrodermatitis of Childhood Associated with Hepatitis A Virus Infection

    Article • Pediatric Dermatology, November 1985, Wiley

    Professor Daniel D Shouval

  257. Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies.

    Article • Journal of Clinical Investigation, July 1985, American Society for Clinical Investigation

    Professor Daniel D Shouval

  258. Human hepatoma-associated cell surface antigen: Identification and characterization by means of monoclonal antibodies

    Article • Hepatology, May 1985, Wiley

    Professor Daniel D Shouval

  259. Conservation from rat to human of cytosolic phosphoenolpyruvate carboxykinase and the control of its gene expression

    Article • FEBS Letters, January 1985, Wiley

    Professor Daniel D Shouval

  260. Development of a novel Clq immunoadsorbent for removal of circulating immunecomplexes: Quantitative isolation of hepatitis B virus surface antigen and immunecomplexes

    Article • Immunology Letters, January 1985, Elsevier

    Professor Daniel D Shouval

  261. Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers

    Article • Journal of Medical Virology, January 1984, Wiley

    Professor Daniel D Shouval

  262. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus

    Article • Journal of Clinical Investigation, August 1983, American Society for Clinical Investigation

    Professor Daniel D Shouval

  263. Aortic Insufficiency Unmasked by a Peritoneovenous Shunt

    Article • Annals of Internal Medicine, July 1983, American College of Physicians

    Professor Daniel D Shouval

  264. Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus

    Article • Nature, August 1982, Springer Science + Business Media

    Professor Daniel D Shouval

  265. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.

    Article • Proceedings of the National Academy of Sciences, January 1982, Proceedings of the National Academy of Sciences

    Professor Daniel D Shouval

  266. Laboratory Stigmata of Connective Tissue Disorders in Asymptomatic Carriers of Hepatitis B Virus

    Article • The American Journal of the Medical Sciences, November 1981, Elsevier

    Professor Daniel D Shouval

  267. Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular Carcinoma

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 1981, New England Journal of Medicine (NEJM/MMS)

    Professor Daniel D Shouval

  268. Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies.

    Article • Proceedings of the National Academy of Sciences, October 1980, Proceedings of the National Academy of Sciences

    Professor Daniel D Shouval

  269. Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line

    Article • Nature, July 1980, Springer Science + Business Media

    Professor Daniel D Shouval

  270. Premature Appearance of Hepatic Phosphoenolpyruvate Carboxykinase in Fetal Rats, Not Mediated by Adenosine 3': 5'-Monophosphate

    Article • FEBS Journal, December 1979, Wiley

    Professor Daniel D Shouval

  271. EFFECT OF CO-TRIMOXAZOLE ON NORMAL CREATININE CLEARANCE

    Article • The Lancet, February 1978, Elsevier

    Professor Daniel D Shouval

  272. Subtypes of Hepatitis B Surface Antigen in Native-Born and Immigrant Israelis

    Article • Vox Sanguinis, December 1976, Wiley

    Professor Daniel D Shouval